Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark Ledwidge

Showing results (11-20 of 109) with videos related to

Pageof 11
Sort By:
European Journal of Heart Failure|October 18, 2005
Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?Jennifer Lewin, Mark Ledwidge, Christina O'Loughlin, et al.
The Pharmacogenomics Journal|March 31, 2022
Correction to: Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic reviewJoseph O'Shea, Mark Ledwidge, Joseph Gallagher, et al.
Cardiac Failure Review|February 2, 2018
Natriuretic Peptide-based Screening and Prevention of Heart FailureJoe Gallagher, Chris Watson, Patricia Campbell, et al.
Journal of Cardiac Failure|April 24, 2007
Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic painNiamh Murphy, Mary Mockler, Mary Ryder, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 1, 2015
A Central Role for Monocyte-Platelet Interactions in Heart FailureNadezhda Glezeva, John F Gilmer, Chris J Watson, et al.
European Journal of Cardiovascular Nursing|November 19, 2003
Specialist nurse supervised in-hospital titration to target dose ACE inhibitor--is it safe and feasible in a community heart failure population?Mary Ryder, Bronagh Travers, Lorna Timmons, et al.
European Journal of Heart Failure|November 28, 2007
Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patientsNiamh F Murphy, Christina O'Loughlin, Mark Ledwidge, et al.
Journal of Cardiac Failure|November 13, 2019
Reducing Heart Failure Risk in People With Diabetes: The STOP HF Midlands ProjectJoseph Gallagher, Stephanie James, Chris Watson, et al.
American Journal of Hypertension|October 17, 2017
B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in HypertensionJoe Gallagher, Chris Watson, Shuaiwei Zhou, et al.
Rural and Remote Health|February 21, 2023
Sustainable protocol-based management of hypertension in one institution in northern MalawiGwonde Hastings, Raymond O'Connor, Meadhbh Hunt, et al.
Pageof 11

Showing results (11-20 of 109) with videos related to

Sort By:
Pageof 11
European Journal of Heart Failure|October 18, 2005
Clinical deterioration in established heart failure: what is the value of BNP and weight gain in aiding diagnosis?Jennifer Lewin, Mark Ledwidge, Christina O'Loughlin, et al.
The Pharmacogenomics Journal|March 31, 2022
Correction to: Pharmacogenetic interventions to improve outcomes in patients with multimorbidity or prescribed polypharmacy: a systematic reviewJoseph O'Shea, Mark Ledwidge, Joseph Gallagher, et al.
Cardiac Failure Review|February 2, 2018
Natriuretic Peptide-based Screening and Prevention of Heart FailureJoe Gallagher, Chris Watson, Patricia Campbell, et al.
Journal of Cardiac Failure|April 24, 2007
Decompensation of chronic heart failure associated with pregabalin in patients with neuropathic painNiamh Murphy, Mary Mockler, Mary Ryder, et al.
Journal of Cardiovascular Pharmacology and Therapeutics|November 1, 2015
A Central Role for Monocyte-Platelet Interactions in Heart FailureNadezhda Glezeva, John F Gilmer, Chris J Watson, et al.
European Journal of Cardiovascular Nursing|November 19, 2003
Specialist nurse supervised in-hospital titration to target dose ACE inhibitor--is it safe and feasible in a community heart failure population?Mary Ryder, Bronagh Travers, Lorna Timmons, et al.
European Journal of Heart Failure|November 28, 2007
Improvement but no cure of left ventricular systolic dysfunction in treated heart failure patientsNiamh F Murphy, Christina O'Loughlin, Mark Ledwidge, et al.
Journal of Cardiac Failure|November 13, 2019
Reducing Heart Failure Risk in People With Diabetes: The STOP HF Midlands ProjectJoseph Gallagher, Stephanie James, Chris Watson, et al.
American Journal of Hypertension|October 17, 2017
B-Type Natriuretic Peptide and Ventricular Dysfunction in the Prediction of Cardiovascular Events and Death in HypertensionJoe Gallagher, Chris Watson, Shuaiwei Zhou, et al.
Rural and Remote Health|February 21, 2023
Sustainable protocol-based management of hypertension in one institution in northern MalawiGwonde Hastings, Raymond O'Connor, Meadhbh Hunt, et al.
Pageof 11